Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods.
BioReliance® End-to-End Solutions encompasses service and support for both emerging biotech and major biopharmaceutical companies that seek to accelerate process development, clinical drug production, and conceptual facilities design
In today’s biopharmaceutical market, sampling your product is critical during every step in the manufacturing process. An imprecise or false positive result can lead to a quarantine as well as the need to repeat the analysis. From your bioreactor to final sterile filtration, the NovaSeptum® sampling system lets you sample processes the way you want. Flexible formats and volumes adapt to your process for robust, reliable monitoring and quality assurance. And with our unique, patented technologies, you get faster turnaround time between samples while minimizing loss of product and the risk of contamination.
Mobius® Single-use Bioreactors are a scalable portfolio of stirred tank bioreactors that provide flexibility by configuring software, hardware, and single-use assemblies for use in suspension and adherent cell culture applications. Visit your nearest M Lab™ Collaboration Center to discover our products and explore ways to solve your toughest challenges in life sciences. #MLabCollaboration
Parteck® MXP is a polyvinyl alcohol-based excipient designed for hot melt extrusion to increase solubility and allow for stable and high drug loads for a broad range of APIs. Visit your nearest M Lab™ Collaboration Center to discover our products and explore ways to solve your toughest challenges in life sciences. #MLabCollaboration
GMP Guidelines around the world require that surfaces that come into contact with drug products shall not be reactive, additive, or absorptive so as to alter the safety, identity, strength, purity, or quality of the drug product beyond the official or other established requirements. Exctractables and leachables validation services demonstrate that the plastic/elastomeric product-contact material will not adversely affect the safety of your drug product.
The Viresolve® Pro Solution provides a comprehensive, flexible template solution for viral clearance within mAb and recombinant protein bioproduction. Visit your nearest M Lab™ Collaboration Center to discover our products and explore ways to solve your toughest challenges in life sciences. #MLabCollaboration
Poor solubility of APIs is a critical challenge in drug development. One formulation technique to address this challenge is hot melt extrusion.
Aggregates in mAb therapeutics pose a risk to patients. Are you considering how best to manage and remove aggregates across your template?
Introducing a new drug to the market is an extensive and intricate process. Development, testing, and registrations take years to complete after a new patent has been commissioned. Expediting approval preparation and maintaining reliable manufacturing processes are crucial for a quick market launch. That’s why MilliporeSigma devised the Emprove® Program. In this video you will learn how this program supports risk assessment and offers assistance in developing more robust processes.
|
|
|
|
|
|
|
|
|